Immune-Mediated Thrombocytopenia Associated With Ad26.COV2.S (Janssen; Johnson & Johnson) Vaccine

Am J Ther. 2021 Aug 20;28(5):e604-e606. doi: 10.1097/MJT.0000000000001431.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Aged
  • COVID-19 Vaccines / administration & dosage
  • COVID-19 Vaccines / adverse effects*
  • COVID-19*
  • Female
  • Humans
  • Purpura, Thrombocytopenic, Idiopathic / chemically induced*
  • SARS-CoV-2
  • Uterine Cervical Neoplasms / complications*
  • Vaccines

Substances

  • COVID-19 Vaccines
  • Vaccines